Dietary factors associated with metabolic risk score in Finnish children aged 6-8 years: the PANIC study. 2014

A M Eloranta, and V Lindi, and U Schwab, and S Kiiskinen, and T Venäläinen, and H M Lakka, and D E Laaksonen, and T A Lakka
Physiology, Institute of Biomedicine, University of Eastern Finland, PO Box 1627, 70211, Kuopio, Finland, aino-maija.eloranta@uef.fi.

OBJECTIVE Previous evidence for the associations of eating frequency and food consumption with clustering of metabolic risk factors among children is limited. We therefore investigated association of the daily number of main meals and snacks and food consumption with a metabolic risk score and individual metabolic risk factors in primary school children. METHODS The subjects were a population sample of Finnish girls and boys 6-8 years of age. Dietary factors were measured by a four-day food record. Metabolic risk score was calculated summing up the Z-scores of waist circumference, systolic and diastolic blood pressure, and concentrations of fasting serum insulin and fasting plasma glucose, triglycerides and high-density lipoprotein cholesterol, the latest multiplying by -1. RESULTS Skipping main meals (standardized regression coefficient β = -0.18, P < 0.001), a higher consumption of non-root vegetables (β = 0.18, P < 0.01), low-fat vegetable-oil-based margarine (β = 0.13, P < 0.01) and sugar-sweetened beverages (β = 0.11, P < 0.05) and a lower consumption of vegetable oils (β = -0.10, P < 0.05) were associated with a higher metabolic risk score after adjustment for age, sex, total physical activity, electronic media time, energy intake and other dietary factors. The consumption of red meat was directly related to the metabolic risk score, but the association was not statistically significant after adjustment for energy intake. CONCLUSIONS Eating main meals regularly, decreasing the consumption of sugar-sweetened beverages and low-fat margarine and increasing the consumption of vegetable oils should be emphasized to reduce metabolic risk among children.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001823 Body Composition The relative amounts of various components in the body, such as percentage of body fat. Body Compositions,Composition, Body,Compositions, Body
D002149 Energy Intake Total number of calories taken in daily whether ingested or by parenteral routes. Caloric Intake,Calorie Intake,Intake, Calorie,Intake, Energy
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children

Related Publications

A M Eloranta, and V Lindi, and U Schwab, and S Kiiskinen, and T Venäläinen, and H M Lakka, and D E Laaksonen, and T A Lakka
January 1978, Revista de pediatrie, obstetrica si ginecologie. Pediatria,
A M Eloranta, and V Lindi, and U Schwab, and S Kiiskinen, and T Venäläinen, and H M Lakka, and D E Laaksonen, and T A Lakka
September 2001, Anales espanoles de pediatria,
A M Eloranta, and V Lindi, and U Schwab, and S Kiiskinen, and T Venäläinen, and H M Lakka, and D E Laaksonen, and T A Lakka
September 1982, Acta paediatrica Scandinavica,
A M Eloranta, and V Lindi, and U Schwab, and S Kiiskinen, and T Venäläinen, and H M Lakka, and D E Laaksonen, and T A Lakka
August 2017, Acta odontologica Scandinavica,
A M Eloranta, and V Lindi, and U Schwab, and S Kiiskinen, and T Venäläinen, and H M Lakka, and D E Laaksonen, and T A Lakka
March 2020, Pediatric diabetes,
A M Eloranta, and V Lindi, and U Schwab, and S Kiiskinen, and T Venäläinen, and H M Lakka, and D E Laaksonen, and T A Lakka
October 2025, BMC public health,
A M Eloranta, and V Lindi, and U Schwab, and S Kiiskinen, and T Venäläinen, and H M Lakka, and D E Laaksonen, and T A Lakka
January 2017, Developmental period medicine,
A M Eloranta, and V Lindi, and U Schwab, and S Kiiskinen, and T Venäläinen, and H M Lakka, and D E Laaksonen, and T A Lakka
September 2023, BMC pediatrics,
A M Eloranta, and V Lindi, and U Schwab, and S Kiiskinen, and T Venäläinen, and H M Lakka, and D E Laaksonen, and T A Lakka
January 2001, American journal of preventive medicine,
A M Eloranta, and V Lindi, and U Schwab, and S Kiiskinen, and T Venäläinen, and H M Lakka, and D E Laaksonen, and T A Lakka
January 2015, Annali dell'Istituto superiore di sanita,
Copied contents to your clipboard!